RA Capital Nexus Fund II, Director: Hemab Therapeutics Holdings COAG Buy · Filed 05/06

Trade details

Type: Insider buy
Amount: $2,142,846.37
Shares · price: 87,143 sh · $24.59 a share
Held after: 6,236,239 sh
Stock: Hemab Therapeutics Holdings COAG
Person: RA Capital Nexus Fund IIDirector
Trade date: 26/05/05
Filed: 26/05/06
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 6 insiders
Holding change: +1.4%

Hemab Therapeutics Holdings trades, last 26 weeks

What else happened in Hemab Therapeutics Holdings around then

Filed or reported within 30 days of the trade day · 04/05~06/04

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$256.7K
10,268 sh
$256.7K
Filed 05/06
Traded 05/05